Lobbying client

TARAXOS

An emerging pharmaceutical company working on treatments to better manage chronic pain

Filings
12
Filed by
1
Reported in-house
—
Reported by firms
$110,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2009 to 2012

Filings

12 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination
2nd Quarter 2012
FABIANI & COMPANY — reported
1st Quarter - Report
1st Quarter 2012
FABIANI & COMPANY — reported
3rd Quarter - Report (No Activity)
3rd Quarter 2011
FABIANI & COMPANY — reported
4th Quarter - Report
4th Quarter 2011
FABIANI & COMPANY — reported
2nd Quarter - Report
2nd Quarter 2011
FABIANI & COMPANY — reported
1st Quarter - Report
1st Quarter 2011
FABIANI & COMPANY — reported
4th Quarter - Report
4th Quarter 2010
FABIANI & COMPANY $10,000 reported
3rd Quarter - Report
3rd Quarter 2010
FABIANI & COMPANY $10,000 reported
2nd Quarter - Report
2nd Quarter 2010
FABIANI & COMPANY $30,000 reported
1st Quarter - Report
1st Quarter 2010
FABIANI & COMPANY $30,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
FABIANI & COMPANY 11 $110,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Defense DEF 8
Veterans VET 8
Medical/Disease Research/Clinical Labs MED 3

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.